Article
The role of technetium-99m methoxyisobutylisonitrile in predicting malignancy of thyroid nodules
Search Medline for
Authors
Published: | April 21, 2016 |
---|
Outline
Text
Background: Technetium-99m methoxyisobutylisonitrile (99Tc-MIBI) is a well-established agent for myocardial perfusion imaging and the preoperative localization of hyperparathyroidism. In addition 99Tc-MIBI scintigraphy is used in the evaluation of thyroid nodules suspicious for malignancy. Because several studies show conflicting results in predicting malignancy of thyroid nodules we report on our experience with 99Tc-MIBI in the diagnostic work up of thyroid pathologies.
Materials and methods: In this retrospective study, we evaluated data of patients who underwent preoperative 99Tc-MIBI scintigraphy and thyroid surgery in our hospital. All 99Tc-MIBI scans were performed by only one referring physician. The uptake of 99Tc-MIBI was compared to normal thyroid tissue. Nodules with an increased uptake were considered MIBI positive. Surgery included single node excision, hemithyroidectomy, subtotal and total thyroidectomy. All specimens resected were histopathologically evaluated and preoperative 99Tc-MIBI results were compared to the histopathological reports.
Results: A total of 115 patients, 86 women and 29 men, were included in the study. In 71 patients (62%) 99Tc-MIBI was positive. Of these only 11 patients (15%) had thyroid malignancy. In 4/44 patients (9%) with a 99Tc-MIBI negative scan histopathology showed a malignant tumor. The sensivity and specifity in detecting malignant thyroid nodules were 69% and 39%, the positive predictive value was 12% and the negative predictive value was 91%.
Conclusion: 99Tc-MIBI is not appropriate to definitely predict malignancy in thyroid nodules. However a 99Tc-MIBI negative scan is highly predictive for benign thyroid pathologies.